David Parke is a Managing Director of EVOLUTION Life Science Partners. Mr. Parke specializes in capital raise and mergers and acquisitions for life science companies. His experience delivers a strong background in capital markets with an in-depth understanding of the issues particular to biotechnology and other development stage companies. He was previously with Burrill Securities, which he joined in 2011, where he managed a number of acquisition and financing engagements for both public and private firms. His experience prior to Burrill includes Boenning & Scattergood and Investec.
Mr. Parke is a Member of the Life Science Advisory Board of IP Group North America. Mr. Parke received his MBA with Honors from The Wharton School of the University of Pennsylvania, and graduated summa cum laude and Phi Beta Kappa from Lehigh University with a B.S. in Finance.